Logo image of HEPS

D-MARKET ELECTRONIC SERV-ADR (HEPS) Stock Fundamental Analysis

NASDAQ:HEPS - Nasdaq - US23292B1044 - ADR - Currency: USD

3.45  -0.1 (-2.82%)

Fundamental Rating

3

Taking everything into account, HEPS scores 3 out of 10 in our fundamental rating. HEPS was compared to 32 industry peers in the Broadline Retail industry. HEPS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, HEPS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HEPS had negative earnings in the past year.
In the past year HEPS had a positive cash flow from operations.
In the past 5 years HEPS reported 4 times negative net income.
Of the past 5 years HEPS 4 years had a positive operating cash flow.
HEPS Yearly Net Income VS EBIT VS OCF VS FCFHEPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2B -2B 4B

1.2 Ratios

The Return On Assets of HEPS (-6.54%) is worse than 74.19% of its industry peers.
With a Return On Equity value of -43.66%, HEPS is not doing good in the industry: 70.97% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROIC N/A
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HEPS Yearly ROA, ROE, ROICHEPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 -50

1.3 Margins

The Gross Margin of HEPS (35.27%) is worse than 67.74% of its industry peers.
HEPS's Gross Margin has improved in the last couple of years.
HEPS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%
HEPS Yearly Profit, Operating, Gross MarginsHEPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 30

More info and screens

5

2. Health

2.1 Basic Checks

HEPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
HEPS has more shares outstanding than it did 1 year ago.
HEPS has less shares outstanding than it did 5 years ago.
HEPS has a better debt/assets ratio than last year.
HEPS Yearly Shares OutstandingHEPS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 100M 200M 300M
HEPS Yearly Total Debt VS Total AssetsHEPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 2.79 indicates that HEPS is not a great score, but indicates only limited risk for bankruptcy at the moment.
HEPS has a Altman-Z score of 2.79. This is in the better half of the industry: HEPS outperforms 61.29% of its industry peers.
HEPS has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
HEPS's Debt to FCF ratio of 0.35 is amongst the best of the industry. HEPS outperforms 87.10% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that HEPS is not too dependend on debt financing.
HEPS has a Debt to Equity ratio of 0.44. This is comparable to the rest of the industry: HEPS outperforms 41.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Altman-Z 2.79
ROIC/WACCN/A
WACC29.76%
HEPS Yearly LT Debt VS Equity VS FCFHEPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.02 indicates that HEPS should not have too much problems paying its short term obligations.
HEPS has a worse Current ratio (1.02) than 90.32% of its industry peers.
HEPS has a Quick Ratio of 1.02. This is a bad value and indicates that HEPS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.66, HEPS is not doing good in the industry: 80.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.66
HEPS Yearly Current Assets VS Current LiabilitesHEPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5B 10B 15B

More info and screens

6

3. Growth

3.1 Past

HEPS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -573.58%.
HEPS shows a strong growth in Revenue. In the last year, the Revenue has grown by 149.58%.
Measured over the past years, HEPS shows a very strong growth in Revenue. The Revenue has been growing by 78.63% on average per year.
EPS 1Y (TTM)-573.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.71%
Revenue 1Y (TTM)149.58%
Revenue growth 3Y77.34%
Revenue growth 5Y78.63%
Sales Q2Q%57.93%

3.2 Future

Based on estimates for the next years, HEPS will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.11% on average per year.
Based on estimates for the next years, HEPS will show a very strong growth in Revenue. The Revenue will grow by 44.58% on average per year.
EPS Next Y-134.57%
EPS Next 2Y3.17%
EPS Next 3Y19.11%
EPS Next 5YN/A
Revenue Next Year75.07%
Revenue Next 2Y55.2%
Revenue Next 3Y44.58%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HEPS Yearly Revenue VS EstimatesHEPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 20B 40B 60B 80B
HEPS Yearly EPS VS EstimatesHEPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

HEPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 40.67, the valuation of HEPS can be described as expensive.
HEPS's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, HEPS is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 40.67
HEPS Price Earnings VS Forward Price EarningsHEPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

HEPS's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HEPS indicates a rather cheap valuation: HEPS is cheaper than 90.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.33
EV/EBITDA 23.35
HEPS Per share dataHEPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

HEPS's earnings are expected to grow with 19.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.17%
EPS Next 3Y19.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HEPS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

D-MARKET ELECTRONIC SERV-ADR

NASDAQ:HEPS (2/21/2025, 8:25:23 PM)

3.45

-0.1 (-2.82%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)12-10 2024-12-10/bmo
Earnings (Next)N/A N/A
Inst Owners14.19%
Inst Owner Change131.04%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.12B
Analysts82.22
Price Target4.23 (22.61%)
Short Float %5.35%
Short Ratio1.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.41%
PT rev (3m)12.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-114.89%
EPS NY rev (3m)-318.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.57%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 40.67
P/S 0.65
P/FCF 8.33
P/OCF 6.17
P/B 11.16
P/tB 44.72
EV/EBITDA 23.35
EPS(TTM)-0.13
EYN/A
EPS(NY)0.08
Fwd EY2.46%
FCF(TTM)0.41
FCFY12%
OCF(TTM)0.56
OCFY16.21%
SpS5.29
BVpS0.31
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.27%
FCFM 7.82%
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%
F-Score4
Asset Turnover2.57
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Debt/EBITDA 1
Cap/Depr 94.74%
Cap/Sales 2.74%
Interest Coverage N/A
Cash Conversion 413.77%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.66
Altman-Z 2.79
F-Score4
WACC29.76%
ROIC/WACCN/A
Cap/Depr(3y)121.47%
Cap/Depr(5y)110.53%
Cap/Sales(3y)3.7%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-573.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.71%
EPS Next Y-134.57%
EPS Next 2Y3.17%
EPS Next 3Y19.11%
EPS Next 5YN/A
Revenue 1Y (TTM)149.58%
Revenue growth 3Y77.34%
Revenue growth 5Y78.63%
Sales Q2Q%57.93%
Revenue Next Year75.07%
Revenue Next 2Y55.2%
Revenue Next 3Y44.58%
Revenue Next 5YN/A
EBIT growth 1Y79.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year252.1%
EBIT Next 3Y95.44%
EBIT Next 5YN/A
FCF growth 1Y411.4%
FCF growth 3Y124.57%
FCF growth 5Y100.63%
OCF growth 1Y855.4%
OCF growth 3Y124.87%
OCF growth 5Y97.22%